The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isNo human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
- What to watchA seizure or unexplained jerks.
How P-21 works
Small neurogenic peptide derived from CNTF — enhances BDNF signaling and adult hippocampal neurogenesis.
Write the structure out, because almost nobody does. The primary literature gives this compound as Ac-DGGL(A)G-NH2 Kazim 2014; the paper that introduced the series writes it as Ac-DGGLAG-NH2 and calls it P21 Li 2010.
That is three separate protease defenses on a four-residue molecule, and each blocks a different enzyme class. The N-terminal acetyl removes the free amine that aminopeptidases require. The C-terminal amide removes the free carboxylate that carboxypeptidases require.
- Injectable
- Nasal
On the goal map: BDNF & neurotrophic signaling (Focus, memory & cognition)
Research on P-214 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
No completed human trial
Correlative data
Limited community use. The published record has none, so what exists here comes from practice rather than a paper.
How the mechanism reads
A peptidergic analog derived from ciliary neurotrophic factor, developed at the NIH. Rodent work reports increased neurogenesis in the hippocampus and improved cognition in Alzheimer's models, without CNTF's weight-loss side effect.
Experimental, animal or cellRemoving the appetite effect while keeping the neurotrophic action is the design goal, and it is why P-21 exists at all — CNTF itself failed clinically partly because of that side effect.
Mechanistic
Sources
- Li B, Wanka L, et al. Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice. FEBS Letters 2010 · PMID 20600002
- Blanchard J, et al. Beneficial effect of a CNTF tetrapeptide on adult hippocampal neurogenesis, neuronal plasticity, and spatial memory in mice. Journal of Alzheimers Disease 2010 · PMID 20952820
- Rockenstein E, et al. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AbetaPP transgenic mice. Journal of Alzheimers Disease 2011 · PMID 21860085
- Kazim SF, et al. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Neurobiology of Disease 2014 · PMID 25046994
- Baazaoui N, Iqbal K. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. Alzheimers Research and Therapy 2017 · PMID 28655344
- Kazim SF, Iqbal K. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease. Molecular Neurodegeneration 2016 · PMID 27400746
P-21 safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Seizure history: BDNF-boosting neurogenic signals can raise network excitability.
- Brain tumor history: it is derived from CNTF, a glial growth signal.
- Pregnancy: neurogenesis drive in developing tissue has no data.
- Unexplained weight loss: the parent protein CNTF suppressed appetite in human trials, and P-21's behavior is unknown.
- Under 25 with depression: no human data exist for mood effects.
What’s expected
- Human effects are unknown, since the data are animal only.
- If the BDNF signal holds, a slow improvement in learning and mood.
- Local irritation where it is applied.
Watch for
- A seizure or unexplained jerks.
- Weight loss that you did not intend.
- New persistent headache or vision change.
- Worsening mood.
Labs that tell you it’s working
- Comprehensive Metabolic Panel (CMP)
- Cortisol
- hs-CRP (C-Reactive Protein, High Sensitivity)
- TSH (Thyroid-Stimulating Hormone)
P-21 is a small CNTF-derived peptide shown to raise BDNF and hippocampal neurogenesis in animals; no human studies exist yet.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
P-21 FAQ4 common questions
- Is P-21 approved for human use?
- No. P-21 is a research compound. No completed randomized human trial has given it yet.
- What is P-21 researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Cortisol; hs-CRP; TSH: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for P-21: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



